Literature DB >> 21280234

CE-MS in biomarker discovery, validation, and clinical application.

Harald Mischak1, Joost P Schanstra.   

Abstract

CE coupled MS (CE-MS) has become an increasingly employed technology in proteome analysis with focus on the identification of biomarker peptides in clinical proteomics. In this review, we will cover technical aspects of CE-MS coupling and highlight the improvements made in the last few years. We examine CE-MS from an application point of view, and evaluate its merits and vices for biomarker discovery and clinical applications. We discuss the principal theoretical and practical obstacles encountered when employing CE-MS (and most other proteomic technologies) for the analysis of body fluids for biomarker discovery. We will present several examples of a successful application of CE-MS for biomarker discovery, implications for disease diagnosis, prognosis, and therapy evaluation, and will discuss current challenges and possible future improvements.
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Mesh:

Substances:

Year:  2010        PMID: 21280234     DOI: 10.1002/prca.201000058

Source DB:  PubMed          Journal:  Proteomics Clin Appl        ISSN: 1862-8346            Impact factor:   3.494


  22 in total

1.  The Possibilities to Improve Kidney Health with Proteomics.

Authors:  Stein Ivar Hallan
Journal:  Clin J Am Soc Nephrol       Date:  2017-07-21       Impact factor: 8.237

Review 2.  Proteomic urinary biomarker approach in renal disease: from discovery to implementation.

Authors:  Joost P Schanstra; Harald Mischak
Journal:  Pediatr Nephrol       Date:  2014-03-15       Impact factor: 3.714

3.  Ultrasensitive sample quantitation via selected reaction monitoring using CITP/CZE-ESI-triple quadrupole MS.

Authors:  Chenchen Wang; Cheng S Lee; Richard D Smith; Keqi Tang
Journal:  Anal Chem       Date:  2012-11-20       Impact factor: 6.986

Review 4.  Capillary zone electrophoresis for bottom-up analysis of complex proteomes.

Authors:  Liangliang Sun; Guijie Zhu; Xiaojing Yan; Zhenbin Zhang; Roza Wojcik; Matthew M Champion; Norman J Dovichi
Journal:  Proteomics       Date:  2015-12-20       Impact factor: 3.984

5.  Diagnosis and Prediction of CKD Progression by Assessment of Urinary Peptides.

Authors:  Joost P Schanstra; Petra Zürbig; Alaa Alkhalaf; Angel Argiles; Stephan J L Bakker; Joachim Beige; Henk J G Bilo; Christos Chatzikyrkou; Mohammed Dakna; Jesse Dawson; Christian Delles; Hermann Haller; Marion Haubitz; Holger Husi; Joachim Jankowski; George Jerums; Nanne Kleefstra; Tatiana Kuznetsova; David M Maahs; Jan Menne; William Mullen; Alberto Ortiz; Frederik Persson; Peter Rossing; Piero Ruggenenti; Ivan Rychlik; Andreas L Serra; Justyna Siwy; Janet Snell-Bergeon; Goce Spasovski; Jan A Staessen; Antonia Vlahou; Harald Mischak; Raymond Vanholder
Journal:  J Am Soc Nephrol       Date:  2015-01-14       Impact factor: 10.121

6.  Mass spectrometry for diabetic nephropathy monitoring: new effective tools for physicians.

Authors:  Annunziata Lapolla; Simona Porcu; Pietro Traldi
Journal:  ISRN Endocrinol       Date:  2012-05-20

Review 7.  Biomarkers in development of psychotropic drugs.

Authors:  K Wiedemann
Journal:  Dialogues Clin Neurosci       Date:  2011       Impact factor: 5.986

8.  Urinary proteomic profiling in severe obesity and obstructive sleep apnoea with CPAP treatment.

Authors:  Ian W Seetho; Adela Ramírez-Torres; Amaya Albalat; William Mullen; Harald Mischak; Robert J Parker; Sonya Craig; Nick Duffy; Kevin J Hardy; Jatin G Burniston; John Ph Wilding
Journal:  Sleep Sci       Date:  2015-07-17

9.  Toward rapid, high-sensitivity, volume-constrained biomarker quantification and validation using backscattering interferometry.

Authors:  Ian R Olmsted; Mohamed Hassanein; Amanda Kussrow; Megan Hoeksema; Ming Li; Pierre P Massion; Darryl J Bornhop
Journal:  Anal Chem       Date:  2014-07-07       Impact factor: 6.986

10.  Proteomics as a Quality Control Tool of Pharmaceutical Probiotic Bacterial Lysate Products.

Authors:  Günter Klein; Joost P Schanstra; Janosch Hoffmann; Harald Mischak; Justyna Siwy; Kurt Zimmermann
Journal:  PLoS One       Date:  2013-06-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.